9月26日，诺普信盘中上涨2.02%，截至10:24，报13.14元/股，成交8924.48万元，换手率0.88%，总市值 132.08亿元。 资金流向方面，主力资金净流入404.98万元，特大单买入605.33万元，占比6.78%，卖出480.94万元，占 比5.39%；大单买入2479.40万元，占比27.78%，卖出2198.81万元，占比24.64%。 诺普信今年以来股价涨20.77%，近5个交易日跌1.50%，近20日涨5.71%，近60日涨27.08%。 分红方面，诺普信A股上市后累计派现17.67亿元。近三年，累计派现6.53亿元。 机构持仓方面，截止2025年6月30日，诺普信十大流通股东中，香港中央结算有限公司位居第三大流通 股东，持股2325.63万股，为新进股东。南方中证1000ETF（512100）位居第九大流通股东，持股649.71 万股，为新进股东。华夏行业景气混合A（003567）退出十大流通股东之列。 责任编辑：小浪快报 今年以来诺普信已经1次登上龙虎榜，最近一次登上龙虎榜为5月27日，当日龙虎榜净买入8599.79万 元；买入总计2.76亿元 ，占总成交额比14.92%；卖出 ...

Core Viewpoint - Noposion's stock price has shown a positive trend this year, with a year-to-date increase of 19.58%, and the company has experienced significant trading activity recently [1][2]. Company Overview - Noposion Agricultural Science Co., Ltd. is located in Bao'an District, Shenzhen, Guangdong Province, and was established on September 18, 1999. It was listed on February 18, 2008. The company specializes in providing integrated agricultural protection products, technologies, and services, with main products including pesticide formulations, plant nutrition, and pesticide adjuvants [2]. - The revenue composition of Noposion includes fresh consumption products (49.14%), insecticides (18.67%), fungicides (15.42%), plant nutrition (8.26%), herbicides (5.80%), plant growth regulators and adjuvants (1.20%), other products (1.09%), crop series (0.26%), and agricultural services and trade (0.15%) [2]. Financial Performance - For the first half of 2025, Noposion achieved operating revenue of 3.679 billion yuan, representing a year-on-year growth of 8.20%. The net profit attributable to the parent company was 648 million yuan, reflecting a year-on-year increase of 17.35% [2]. - Since its A-share listing, Noposion has distributed a total of 1.767 billion yuan in dividends, with 653 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, Noposion had 43,800 shareholders, an increase of 21.47% from the previous period. The average circulating shares per person decreased by 17.01% to 17,944 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third-largest shareholder with 23.2563 million shares, while Southern CSI 1000 ETF is the ninth largest with 6.4971 million shares, both being new shareholders [3].

Group 1 - Global Printing announced that shareholder Hong Kong Yuanshi International Co., Ltd. plans to reduce its stake by up to 3.2004 million shares, accounting for 1% of the total share capital, due to personal funding needs [1] - Sunflower intends to acquire 100% equity of Xi Pu Materials and 40% equity of Zhejiang Beid Pharmaceutical through a combination of share issuance and cash payment, with stock resuming trading on September 22, 2025 [1][2] - Crown Zhong Ecology is planning a change in control, leading to a temporary suspension of its stock and convertible bonds due to significant uncertainties [2] Group 2 - China Oil Engineering's wholly-owned subsidiary signed a $513 million EPC contract for an LNG pipeline project in the UAE, covering approximately 180.5 kilometers of natural gas pipeline with a 36-month construction period [3] - Shanxi Fenjiu announced that shareholder Huachuang Xinrui (Hong Kong) Co., Ltd. plans to reduce its stake by up to 16.2006 million shares, representing no more than 1.33% of the total share capital [4] - Brother Technology's subsidiary received a drug registration certificate for Iopamidol injection, which is included in the national medical insurance catalog [5] Group 3 - Lin Yang Energy is expected to win a bid for a metering equipment project from the State Grid, with an estimated total bid amount of approximately 142 million yuan [6] - Huahai Chengke received approval from the China Securities Regulatory Commission for issuing shares and convertible bonds to purchase assets and raise no more than 800 million yuan in matching funds [8] - Jindi Co. signed a framework agreement to acquire controlling interest in Unico Precision, which specializes in manufacturing gears and automotive parts [10] Group 4 - Ruifeng High Materials announced that its major shareholder plans to reduce its stake by up to 2.4 million shares, accounting for 0.9584% of the total share capital [12] - Changliang Technology's director plans to reduce his stake by 1.05 million shares, representing 0.129% of the total share capital [14] - Zhongjing Food's director plans to reduce his stake by up to 150,000 shares, accounting for 0.10% of the total share capital [16] Group 5 - Haitai Technology announced that two shareholders plan to reduce their stakes by a total of up to 2.53% of the total share capital [18] - Zhenlei Technology's chairman is under detention but the company states that control has not changed and operations remain normal [20] - Huakang Co. plans to distribute a cash dividend of 0.2 yuan per share, totaling approximately 60.61 million yuan [19]

南方中证1000ETF（512100）成立日期2016年9月29日，最新规模649.53亿。今年以来收益28.17%，同 类排名1822/4222；近一年收益72.87%，同类排名1263/3804；成立以来收益13.43%。 9月18日，诺普信涨5.04%，截至发稿，报13.34元/股，成交4.19亿元，换手率4.06%，总市值134.09亿 元。 资料显示，深圳诺普信作物科学股份有限公司位于广东省深圳市宝安区西乡水库路113号(仅作办公 用)，成立日期1999年9月18日，上市日期2008年2月18日，公司主营业务涉及农业植保产品、技术、服 务一体化提供商,主要产品包括农药制剂、植物营养、农药助溶剂等。主营业务收入构成为：生鲜消费 类49.14%，杀虫剂18.67%，杀菌剂15.42%，植物营养8.26%，除草剂5.80%，植物生长调节剂及助剂类 1.20%，其他1.09%，作物系列0.26%，农业服务及贸易0.15%。 从诺普信十大流通股东角度 数据显示，南方基金旗下1只基金位居诺普信十大流通股东。南方中证1000ETF（512100）二季度新进 十大流通股东，持有股数649.71万股，占流通股的比例为 ...

Core Viewpoint - The company, Baismei, has established a comprehensive industrial chain in its self-produced pesticide business, covering pesticide intermediates, active ingredients, and formulations, emphasizing technology research and development as a key driver for growth [2] Group 1: Business Operations - The company has a complete system for research and development, intermediate production, active ingredient synthesis, and formulation processing [2] - Baismei focuses on independent research and development, supplemented by collaborative development, ensuring continuous transformation of research results into productivity [2] Group 2: Product Quality - The core process technology developed by the company supports its production in various segments, with the concentration and impurity levels of its dimethyl tetrachloride active ingredient meeting or exceeding the standards and requirements of developed countries [2] Group 3: Market Expansion - The subsidiary, Ningbo Jielike, has established sales channels in 79 countries and regions, enhancing the company's ability to expand into international markets through its independent registration model and channel resources [2]

Core Viewpoint - The company reported a decline in revenue and net profit for the first half of 2025, but showed signs of recovery in the second quarter, particularly in its crop protection and organic silicon segments [1][2][3]. Financial Performance - In H1 2025, the company achieved revenue of 8.058 billion yuan, a year-on-year decrease of 5.1%, and a net profit attributable to shareholders of 69.07 million yuan, down 47.7% [1]. - Q2 2025 revenue was 4.436 billion yuan, a year-on-year decline of 1.7% but a quarter-on-quarter increase of 22.4%, with net profit of 35.94 million yuan, up 74.6% year-on-year and 8.5% quarter-on-quarter [1]. - The gross profit for H1 2025 was 868 million yuan, a year-on-year increase of 3.7%, with a gross margin of 10.8%, up 0.9 percentage points year-on-year [3]. Segment Performance - The crop protection business generated revenue of 2.87 billion yuan in H1 2025, a year-on-year increase of 14.8%, with sales volume of 152,000 tons, up 16.0% year-on-year [1]. - In Q2 2025, the crop protection segment saw revenue of 1.77 billion yuan, a year-on-year increase of 23.4% and a quarter-on-quarter increase of 60.1% [1]. - The organic silicon segment reported revenue of 1.87 billion yuan in H1 2025, a year-on-year decrease of 14.5%, with sales volume of 132,000 tons, down 8.3% year-on-year [2]. Price Trends - The average price of glyphosate showed a U-shaped trend in H1 2025, with a market price of 27,100 yuan per ton as of August 21, 2025, up 13.9% from the beginning of the year [1]. - The average price of DMC in Q2 2025 was 12,200 yuan per ton, down 11% year-on-year and 9% quarter-on-quarter [2]. Strategic Initiatives - The company announced a valuation enhancement plan aimed at improving operational quality, competitive advantages, and shareholder returns through stable cash dividends and better investor relations [3]. - The company expects a recovery in the industry’s economic conditions, projecting net profits of 210 million yuan, 620 million yuan, and 790 million yuan for 2025-2027 [3].

Company Overview - Shenzhen Noposion Crop Science Co., Ltd. is located in Bao'an District, Shenzhen, Guangdong Province, and was established on September 18, 1999. The company went public on February 18, 2008. Its main business involves providing integrated agricultural protection products, technology, and services, including pesticide formulations, plant nutrition, and pesticide adjuvants [2]. Business Performance - For the first half of 2025, Noposion achieved operating revenue of 3.679 billion yuan, representing a year-on-year growth of 8.20%. The net profit attributable to the parent company was 648 million yuan, with a year-on-year increase of 17.35% [2]. - The revenue composition includes fresh consumption products (49.14%), insecticides (18.67%), fungicides (15.42%), plant nutrition (8.26%), herbicides (5.80%), plant growth regulators and adjuvants (1.20%), other products (1.09%), crop series (0.26%), and agricultural services and trade (0.15%) [2]. Stock Performance - On September 16, Noposion's stock price increased by 2.37%, reaching 12.53 yuan per share, with a trading volume of 181 million yuan and a turnover rate of 1.86%. The total market capitalization is 12.595 billion yuan [1]. - Year-to-date, Noposion's stock price has risen by 15.17%, with a 5-day increase of 5.74%, a 20-day decline of 3.62%, and a 60-day increase of 19.56% [1]. Shareholder Information - As of June 30, 2025, the number of shareholders for Noposion was 43,800, an increase of 21.47% from the previous period. The average circulating shares per person decreased by 17.01% to 17,944 shares [2]. - The company has distributed a total of 1.767 billion yuan in dividends since its A-share listing, with 653 million yuan distributed over the past three years [3]. Institutional Holdings - Among the top ten circulating shareholders as of June 30, 2025, Hong Kong Central Clearing Limited is the third-largest shareholder with 23.2563 million shares, a new addition. Southern CSI 1000 ETF (512100) ranks as the ninth-largest shareholder with 6.4971 million shares, also a new addition. Huaxia Industry Prosperity Mixed Fund (003567) has exited the top ten circulating shareholders list [3].

Investment Rating - The report maintains a "Strong Buy" rating for Yangnong Chemical (600486) with a target price of 91 CNY per share [2][7]. Core Views - The company's performance continues to improve, with a notable increase in revenue and net profit in the first half of 2025. The company declared a cash dividend of 2.40 CNY per 10 shares [7][8]. - The report highlights the resilience of the raw material segment and the improvement in the profitability of the formulation segment. The company has successfully navigated challenges such as price declines and tariffs [7][8]. - The report anticipates strong growth in the agricultural chemical sector, with the company's net profit expected to reach 1.424 billion CNY in 2025, reflecting an 18.5% year-on-year increase [3][7]. Financial Summary - **Revenue Forecast**: Projected total revenue for 2024 is 10,435 million CNY, increasing to 12,702 million CNY in 2025, with a year-on-year growth rate of 21.7% [3][8]. - **Net Profit Forecast**: Expected net profit for 2024 is 1,202 million CNY, rising to 1,424 million CNY in 2025, with a growth rate of 18.5% [3][8]. - **Earnings Per Share (EPS)**: EPS is projected to be 2.97 CNY in 2024, increasing to 3.51 CNY in 2025 [3][8]. - **Valuation Ratios**: The price-to-earnings (P/E) ratio is expected to decrease from 24 in 2024 to 21 in 2025, indicating a more attractive valuation as earnings grow [3][8]. Market Position - Yangnong Chemical holds a significant market share in the health medicine sector, with approximately 70% market share in domestic and Southeast Asian markets, making it the second-largest supplier globally [7][8]. - The company is well-positioned to benefit from increasing demand for mosquito control and other health-related products due to rising public health concerns [7][8].

Group 1 - The company Hunan Haili announced a share buyback of approximately 3.2 million shares, representing 0.5721% of its total share capital, with a total expenditure of about 22.26 million RMB [1] - The highest and lowest prices for the repurchased shares were 7.01 RMB and 6.88 RMB per share, respectively [1] - For the year 2024, the company's revenue composition is 91.15% from pesticide formulations and 8.85% from lithium batteries [1] Group 2 - The current market capitalization of Hunan Haili is 4.1 billion RMB [2]

(上合天津峰会)挖掘新机遇 上合组织经贸往来活力强劲 中新社天津8月30日电 (记者 刘亮)3000亿、4000亿、5000亿美元……近五年来，中国与上海合作组织其 他成员国贸易额接连突破千亿美元大关。据中国商务部统计，这一数据在2024年约为5124亿美元，创历 史新高。 贸易数据持续攀升，彰显上合组织区域经贸往来的强劲活力，也折射出通道建设的持续优化与通关便利 化水平的不断提升。 近日，山东中欧班列"上合快线"首班点对点供应链专列(中国上合示范区—俄罗斯阿拉布加经济特区)抵 达俄罗斯鞑靼斯坦共和国阿拉布加经济特区。得益于"量身定制"的物流供应链解决方案，"中国造"家电 器件的跨境运输时间较传统路线缩短至14天，时效提高近30%。 例如，新业态新领域快速发展。以跨境电商为例，2024年，中国自其他成员国跨境电商进口同比增长 34%，越来越多优质特色产品通过电商渠道进入中国市场。与此同时，中国电商平台近年来在哈萨克斯 坦等国不断加强本土化服务，如在平台上线当地语言等，让当地消费者无需再借助翻译软件"海淘"中国 好物。 在全球能源绿色转型、新一轮科技革命加速的背景下，上合组织成员国也积极挖掘经贸合作新机遇。 中 ...